vs
BALCHEM CORP（BCPC）与INNOSPEC INC.（IOSP）财务数据对比。点击上方公司名可切换其他公司
INNOSPEC INC.的季度营收约是BALCHEM CORP的1.7倍（$455.6M vs $263.6M）。BALCHEM CORP净利率更高（14.9% vs 10.4%，领先4.5%）。BALCHEM CORP同比增速更快（9.8% vs -2.4%）。过去两年BALCHEM CORP的营收复合增速更高（4.9% vs -4.6%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
Innospec Inc.是一家美国特种化学品企业，前身为奥克泰尔公司及联合奥克泰尔有限公司，旗下设有三大业务板块：高性能化学品业务覆盖个人护理、家居护理、农化、采矿及工业市场；燃料特种化学品业务专注于生产和供应燃油添加剂；油田服务业务则提供钻井、完井及采油相关化学品。
BCPC vs IOSP — 直观对比
营收规模更大
IOSP
是对方的1.7倍
$263.6M
营收增速更快
BCPC
高出12.2%
-2.4%
净利率更高
BCPC
高出4.5%
10.4%
两年增速更快
BCPC
近两年复合增速
-4.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $455.6M |
| 净利润 | $39.2M | $47.4M |
| 毛利率 | 35.6% | 28.0% |
| 营业利润率 | 19.8% | 10.3% |
| 净利率 | 14.9% | 10.4% |
| 营收同比 | 9.8% | -2.4% |
| 净利润同比 | 16.8% | 167.3% |
| 每股收益（稀释后） | $1.21 | $1.90 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCIOSP
| Q4 25 | $263.6M | $455.6M | ||
| Q3 25 | $267.6M | $441.9M | ||
| Q2 25 | $255.5M | $439.7M | ||
| Q1 25 | $250.5M | $440.8M | ||
| Q4 24 | $240.0M | $466.8M | ||
| Q3 24 | $239.9M | $443.4M | ||
| Q2 24 | $234.1M | $435.0M | ||
| Q1 24 | $239.7M | $500.2M |
净利润BCPCIOSP
| Q4 25 | $39.2M | $47.4M | ||
| Q3 25 | $40.3M | $12.9M | ||
| Q2 25 | $38.3M | $23.5M | ||
| Q1 25 | $37.1M | $32.8M | ||
| Q4 24 | $33.6M | $-70.4M | ||
| Q3 24 | $33.8M | $33.4M | ||
| Q2 24 | $32.1M | $31.2M | ||
| Q1 24 | $29.0M | $41.4M |
毛利率BCPCIOSP
| Q4 25 | 35.6% | 28.0% | ||
| Q3 25 | 35.7% | 26.4% | ||
| Q2 25 | 36.4% | 28.0% | ||
| Q1 25 | 35.2% | 28.4% | ||
| Q4 24 | 36.0% | 29.2% | ||
| Q3 24 | 35.6% | 28.0% | ||
| Q2 24 | 35.5% | 29.2% | ||
| Q1 24 | 34.0% | 31.1% |
营业利润率BCPCIOSP
| Q4 25 | 19.8% | 10.3% | ||
| Q3 25 | 20.4% | 1.3% | ||
| Q2 25 | 20.1% | 7.8% | ||
| Q1 25 | 20.4% | 9.6% | ||
| Q4 24 | 19.8% | 8.8% | ||
| Q3 24 | 20.0% | 10.3% | ||
| Q2 24 | 19.6% | 9.4% | ||
| Q1 24 | 17.4% | 10.1% |
净利率BCPCIOSP
| Q4 25 | 14.9% | 10.4% | ||
| Q3 25 | 15.1% | 2.9% | ||
| Q2 25 | 15.0% | 5.3% | ||
| Q1 25 | 14.8% | 7.4% | ||
| Q4 24 | 14.0% | -15.1% | ||
| Q3 24 | 14.1% | 7.5% | ||
| Q2 24 | 13.7% | 7.2% | ||
| Q1 24 | 12.1% | 8.3% |
每股收益（稀释后）BCPCIOSP
| Q4 25 | $1.21 | $1.90 | ||
| Q3 25 | $1.24 | $0.52 | ||
| Q2 25 | $1.17 | $0.94 | ||
| Q1 25 | $1.13 | $1.31 | ||
| Q4 24 | $1.03 | $-2.80 | ||
| Q3 24 | $1.03 | $1.33 | ||
| Q2 24 | $0.98 | $1.24 | ||
| Q1 24 | $0.89 | $1.65 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $292.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $1.3B |
| 总资产 | $1.7B | $1.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCPCIOSP
| Q4 25 | $74.6M | $292.5M | ||
| Q3 25 | $65.1M | $270.8M | ||
| Q2 25 | $65.4M | $266.6M | ||
| Q1 25 | $49.9M | $299.8M | ||
| Q4 24 | $49.5M | $289.2M | ||
| Q3 24 | $73.7M | $303.8M | ||
| Q2 24 | $63.7M | $240.2M | ||
| Q1 24 | $60.3M | $270.1M |
股东权益BCPCIOSP
| Q4 25 | $1.3B | $1.3B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $1.1B | $1.2B | ||
| Q1 24 | $1.1B | $1.2B |
总资产BCPCIOSP
| Q4 25 | $1.7B | $1.8B | ||
| Q3 25 | $1.7B | $1.8B | ||
| Q2 25 | $1.7B | $1.8B | ||
| Q1 25 | $1.6B | $1.8B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.6B | $1.8B | ||
| Q2 24 | $1.6B | $1.7B | ||
| Q1 24 | $1.6B | $1.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $61.4M |
| 自由现金流经营现金流 - 资本支出 | — | $46.8M |
| 自由现金流率自由现金流/营收 | — | 10.3% |
| 资本支出强度资本支出/营收 | — | 3.2% |
| 现金转化率经营现金流/净利润 | 1.72× | 1.30× |
| 过去12个月自由现金流最近4个季度 | — | $88.0M |
8季度趋势，按日历期对齐
经营现金流BCPCIOSP
| Q4 25 | $67.3M | $61.4M | ||
| Q3 25 | $65.6M | $39.3M | ||
| Q2 25 | $47.3M | $9.3M | ||
| Q1 25 | $36.5M | $28.3M | ||
| Q4 24 | $52.3M | $25.7M | ||
| Q3 24 | $51.3M | $73.5M | ||
| Q2 24 | $45.0M | $4.7M | ||
| Q1 24 | $33.4M | $80.6M |
自由现金流BCPCIOSP
| Q4 25 | — | $46.8M | ||
| Q3 25 | — | $25.0M | ||
| Q2 25 | — | $-3.7M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | — | $13.6M | ||
| Q3 24 | — | $65.8M | ||
| Q2 24 | — | $-6.2M | ||
| Q1 24 | — | $69.9M |
自由现金流率BCPCIOSP
| Q4 25 | — | 10.3% | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | -0.8% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | — | 14.8% | ||
| Q2 24 | — | -1.4% | ||
| Q1 24 | — | 14.0% |
资本支出强度BCPCIOSP
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 2.1% |
现金转化率BCPCIOSP
| Q4 25 | 1.72× | 1.30× | ||
| Q3 25 | 1.63× | 3.05× | ||
| Q2 25 | 1.23× | 0.40× | ||
| Q1 25 | 0.98× | 0.86× | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | 2.20× | ||
| Q2 24 | 1.40× | 0.15× | ||
| Q1 24 | 1.15× | 1.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
IOSP
| Refinery And Performance | $147.0M | 32% |
| Personal Care | $99.7M | 22% |
| Oilfield Services | $93.1M | 20% |
| Other Fuel Specialties | $47.1M | 10% |
| Other Performance Chemicals | $40.0M | 9% |
| Home Care | $28.7M | 6% |
